Carbohydrate feeding dissociates the postprandial FGF19 response from circulating bile acid levels in humans.
暂无分享,去创建一个
[1] R. Bergman,et al. FGF19 action in the brain induces insulin-independent glucose lowering. , 2013, The Journal of clinical investigation.
[2] A. Honda,et al. FGF15/19 protein levels in the portal blood do not reflect changes in the ileal FGF15/19 or hepatic CYP7A1 mRNA levels , 2013, Journal of Lipid Research.
[3] W. Strodel,et al. A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass , 2013, Diabetes Care.
[4] J. H. Bekker,et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. , 2012, Endocrinology.
[5] Jun Li,et al. Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1 , 2011, Science Translational Medicine.
[6] S. Kliewer,et al. FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway. , 2011, Cell metabolism.
[7] S. Kliewer,et al. FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis , 2011, Science.
[8] A. Peterson,et al. FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways , 2011, PloS one.
[9] R. Sherwood,et al. The relationship between postprandial bile acid concentration, GLP‐1, PYY and ghrelin , 2011, Clinical Endocrinology.
[10] F. G. Benedict,et al. A biometric study of basal metabolism in man , 2010 .
[11] M. Mohammadi,et al. The FGF family: biology, pathophysiology and therapy , 2009, Nature Reviews Drug Discovery.
[12] S. Strom,et al. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α‐hydroxylase gene expression , 2009, Hepatology.
[13] M. Thorner,et al. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. , 2008, The Journal of clinical endocrinology and metabolism.
[14] T. Lundåsen,et al. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man , 2006, Journal of internal medicine.
[15] B. Angelin,et al. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. , 2005, Gastroenterology.
[16] Christoph Handschin,et al. Metabolic control through the PGC-1 family of transcription coactivators. , 2005, Cell metabolism.
[17] R. Soriano,et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. , 2004, Endocrinology.
[18] S. Kliewer,et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. , 2003, Genes & development.
[19] G. Waeber,et al. Glucagon-Like Peptide-I and the Control of Insulin Secretion in the Normal State and in NIDDM , 1993, Diabetes.
[20] S. Woods,et al. Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. , 2013, Endocrinology.
[21] B. Staels,et al. Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.
[22] W. Hopman,et al. Gallbladder responses to modified sham feeding: effects of the composition of a meal. , 1993, Journal of hepatology.